Literature DB >> 15607921

New aspects on the preparation of [11C]Methionine--a simple and fast online approach without preparative HPLC.

Markus Mitterhauser1, Wolfgang Wadsak, Andreas Krcal, Joern Schmaljohann, Harald Eidherr, Alexander Schmid, Helmut Viernstein, Robert Dudczak, Kurt Kletter.   

Abstract

At present, most data available on PET imaging of brain tumors using amino acids are based on l-[S-methyl-11C]methionine (MET). This radiopharmaceutical accurately delineates tumor extent, sometimes even better than CT. Since MET is playing such an important role for PET, a potent preparation method for this radiotracer allowing frequent syntheses for PET routine is desirable. Therefore, a simple disposable synthesis module was conceived without HPLC purification. Using a solid supported [11C]methylation on Al2O3 leads to the simplification of the preparation requiring only filtration for separation of precursor and MET. The presented method is able to produce high purity MET in excellent yields enough to serve several consecutive patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607921     DOI: 10.1016/j.apradiso.2004.07.006

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  8 in total

Review 1.  Non-FDG PET/CT in Diagnostic Oncology: a pictorial review.

Authors:  Francesco Giammarile; Paolo Castellucci; Rudi Dierckx; Enrique Estrada Lobato; Mohsen Farsad; Roland Hustinx; Amirreza Jalilian; Olivier Pellet; Susana Rossi; Diana Paez
Journal:  Eur J Hybrid Imaging       Date:  2019-11-29

2.  Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

Authors:  Egesta Lopci; Marco Riva; Laura Olivari; Fabio Raneri; Riccardo Soffietti; Arnoldo Piccardo; Alberto Bizzi; Pierina Navarria; Anna Maria Ascolese; Roberta Rudà; Bethania Fernandes; Federico Pessina; Marco Grimaldi; Matteo Simonelli; Marco Rossi; Tommaso Alfieri; Paolo Andrea Zucali; Marta Scorsetti; Lorenzo Bello; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-21       Impact factor: 9.236

3.  Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.

Authors:  Nina Poetsch; Adelheid Woehrer; Johanna Gesperger; Julia Furtner; Alexander R Haug; Dorothee Wilhelm; Georg Widhalm; Georgios Karanikas; Michael Weber; Ivo Rausch; Markus Mitterhauser; Wolfgang Wadsak; Marcus Hacker; Matthias Preusser; Tatjana Traub-Weidinger
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

4.  **-Postprandial pancreatic [11C]methionine uptake after pancreaticoduodenectomy mirrors basal beta cell function and insulin release.

Authors:  Emanuel Steiner; Lukas Kazianka; Robert Breuer; Marcus Hacker; Wolfgang Wadsak; Markus Mitterhauser; Thomas Stimpfl; Birgit Reiter; Georgios Karanikas; Johannes Miholic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-07       Impact factor: 9.236

5.  The prognostic value of [123I]-vascular endothelial growth factor ([123I]-VEGF) in glioma.

Authors:  Eva Rainer; Hao Wang; Tatjana Traub-Weidinger; Georg Widhalm; Barbara Fueger; Jingling Chang; Zhaohui Zhu; Christine Marosi; Alexander Haug; Marcus Hacker; Shuren Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-30       Impact factor: 9.236

Review 6.  Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering.

Authors:  Joham Surfraz Ali; Noor Ul Ain; Sania Naz; Muhammad Zia
Journal:  Heliyon       Date:  2020-02-03

7.  11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy.

Authors:  W A Bashari; M van der Meulen; J MacFarlane; D Gillett; R Senanayake; L Serban; A S Powlson; A M Brooke; D J Scoffings; J Jones; D G O'Donovan; J Tysome; T Santarius; N Donnelly; I Boros; F Aigbirhio; S Jefferies; H K Cheow; I A Mendichovszky; A G Kolias; R Mannion; O Koulouri; M Gurnell
Journal:  Pituitary       Date:  2022-05-24       Impact factor: 3.599

8.  18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.

Authors:  György Trencsényi; Teréz Márián; Imre Lajtos; Zoltán Krasznai; László Balkay; Miklós Emri; Pál Mikecz; Katalin Goda; Gábor Szalóki; István Juhász; Enikő Németh; Tünde Miklovicz; Gábor Szabó; Zoárd T Krasznai
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.